Home › Funds › Point72 Asset Management › TNXP
Point72 Asset Management position in TNXP
TONIX PHARMACEUTICALS HLDG C · Health Care
Latest position (Q2 2026)1.17M sh
Reported value held$14.89M
Portfolio Weight0.06%
First reportedQ4 2025
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 620.03K | $9.68M | New |
| Q1 2026 | 125.41K | $1.72M | Reduce |
| Q2 2026 | 1.17M | $14.89M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding TNXP
- BlackRock Inc 1.40M sh · $17.84M · Q2 2026
- Millennium Management 966.93K sh · $12.34M · Q2 2026
- AQR Capital Management 882.60K sh · $11.26M · Q2 2026
- Vanguard Group 673.61K sh · $10.52M · Q4 2025
- Geode Capital Management 395.26K sh · $5.04M · Q2 2026
- UBS Group AG 231.68K sh · $2.96M · Q2 2026
- Balyasny Asset Management 132.59K sh · $1.69M · Q2 2026
- Northern Trust Corp 120.39K sh · $1.54M · Q2 2026
- Goldman Sachs Group 98.36K sh · $1.26M · Q2 2026
- Fidelity Management & Research (FMR) 93.55K sh · $1.19M · Q2 2026
- Bank of America Corp 60.98K sh · $778.07K · Q2 2026